https://www.selleckchem.com/products/e-7386.html
0% vs 3.3%; RR 1.24, 95% CI 1.11-1.38, p = 0.0002). There was a modest but still significant association in the lowerdose (n-3 FA ≤ 1g daily) sub-group (RR 1.12, 95% CI 1.04-1.21, p = 0.004) and stronger association in the higherdose (n-3 FA 1g daily) sub-group (RR 1.51, 95% CI 1.26-1.80, p 0.001; p-interaction between low versus high subgroups = 0.003). There was no increase in stroke risk (RR 1.04, 95% CI 0.90-1.2. Meta-regression demonstrated a significant association between dose of n-3 FA with risk for AF events (log RR
Like
Comment
Share
